GlassScriptPhysician profile
Andrew L Simon
NPI 1992767388
$911.22
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $244 · 2021: $151 · 2022: $291 · 2023: $15.88 · 2024: $55.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $211.74 | 2019-2023 | Myrbetriq |
| Stryker Corporation | $150.79 | 2019-2024 | T2 Alpha |
| Depuy Synthes Sales INC. | $144.19 | 2022 | |
| Medtronic, INC. | $109.93 | 2021-2022 | |
| Neotract INC. | $84.76 | 2020 | |
| Myovant Sciences INC. | $81.24 | 2021 | |
| Medtronic USA, INC. | $30.72 | 2019 | |
| Teleflex LLC | $30.58 | 2021-2022 | |
| Pfizer INC. | $29.26 | 2019 | |
| Tolmar, INC. | $16.88 | 2024 | |
| Antares Pharma, INC. | $12.40 | 2022 | |
| Clarus Therapeutics INC. | $8.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.